High affinity, GABA plasma membrane transporters influence the action of GABA, the main inhibitory neurotransmitter. The cellular expression of GAT-1, a prominent GABA transporter, has been investigated in the cerebral cortex of adult rats using in situ hybridizaton with %-labeled RNA probes and immunocytochemistry with affinity purified polyclonal antibodies directed to the C-terminus of rat GAT-1.
GAT-1 mRNA was observed in numerous neurons and in some glial cells. Double-labeling experiments were performed to compare the pattern of GAT-1 mRNA containing and GAD67 immunoreactive cells. The majority of neurons expressing GAT-1 mRNA also contained GAD67 immunoreactivity (ir), but GAT-1 mRNA was also observed in a few pyramidal neurons. GAT-I-ir was localized to numerous puncta and fibers and to astrocytic processes, was not observed in sections incubated in GAT-1 antibodies preadsorbed with rat GAT-1 C-terminal peptide, and was observed in sections incubated in GAT-1 antibodies preadsorbed with the C-terminal portion of the related peptides rat GATS,,,.,,, or rat glycine transporter-l,,,,,,.
The highest number of GAT-1-ir puncta was in layer IV, followed by .layers 11-111. GAT-1 positive puncta appeared to have a preferential relationship to the soma and proximal dendrites of unlabeled pyramidal cells. All GAT-1 positive axon terminals formed symmetric synapses.
This study demonstrates that (1) GAT-1 is expressed by both neurons and astrocytes, (2) the majority of GAT-1 expressing neurons contain GAD67, and (3) GAT-1 uptake system is more extensive than the GABA synthetizing system. These observations support the hypothesis that, in addition to its role in terminating GABA action by uptake into GABAergic axon terminals, GAT-1 influences both excitatory and inhibitory transmission by modulating the "paracrine" spread of GABA (Isaacson et al., 1993) , and suggest that astrocytes may play an important role in this process.
[Key words : GABA, GABA transporlers, neocottex, synapses, neurons, astrocytes] Synaptic transmission mediated by GABA plays a key role in controlling neuronal activity and information processing in the mammalian cerebral cortex (Krnjevic, 1984; Sillito, 1984; McCormick et al., 1993) . The organization of the GABA system has been extensively studied, using immunocytochemistry (ICC) and in sits hybridization histochemistry (ISH) to visualize GABA or its synthetic enzymes, glutamic acid decarboxylase 65 and 67 (GAD65 and GAD67; Erlander et al., 1991) . The availability of antibodies and cDNAs encoding GAD65 and 67 has allowed for a detailed characterization of the number, morphology, and distribution of cortical neurons synthetizing GABA and of their synapses (Ribak, 1978; Emson and Hunt, 1981; Houser et al., 1983 Houser et al., , 1984 Somogyi and Martin, 1985; Fitzpatrick et al., 1987; Hendry et al., 1987; Freund and Meskenaite, 1992; Hendry and Carder, 1992; Beaulieu, 1993; Jones, 1993) . In general, GABA and GAD are expressed by nonpyramidal neurons that make symmetric synaptic contacts on the cell bodies and proximal dendrites of both pyramidal and nonpyramidal cells (Hendry and Carder, 1992; Jones, 1993) . These observations have been complemented by defining the distribution of GABA receptor subunit mRNAs and proteins within the cortex (deBlas et al., 1988; Somogyi, 1989; Hendry et al., 1990; Huntley et al., 1990; Wisden et al., 1992; Gu et al., 1993; Huntsman et al., 1994) . Whereas much has been learnt about GABAergic neurons and synapses, little is known about the distribution of plasma membrane transporters that mediate GABA uptake into nerve endings and/or surrounding glial processes (Iversen and Neal, 1968; Iversen and Snyder, 1968; Neal and Iversen, 1969; Bloom and Iversen, 1970; Iversen, 197 1; Hokfelt and Ljungdahl, 1972; Iversen and Kelly, 1975; Kanner, 1978; Schousboe, 1981; Kanner and Shuldiner, 1987; Radian et al., 1990) . GABA transporters play an important role in the regulation of the magnitude and duration of GABA's action (Isaacson et al., 1993; Mager et al., 1993) and may also release GABA into the extracellular space in a Ca*+-independent, nonvesicular manner (Schwartz, 1982; Pin and Bockaert, 1989; Attwell et al., 1993; Levi and Raiteri, 1993 ). Fig we I. A, Distribution of GAT-1 mRNAs in a parasagittal section of an adult rat, incubated with the antisense GAT-1 RNA probe and expc for 15 d. Note the high levels of hybridization signal in brainstem, basal forebrain, cerebellum, and cerebral neocortex. B, A corresponding set pro cessed with the sense GAT-1 RNA probe and exposed for 15 d. Scale bar, 5 mm.
Zion
Four cDNAs encoding GABA transporters (GATs) have been localized in the rodent and human nervous system (Guastella et al., 1990; .Borden et al., 1992; Brecha et al., 1992; Clark et al., 1992; Liu et al., 1993; Borden et al., 1994a) . These transporters share a high degree of nucleotide and amino acid sequence homology, and they transport GABA in a high affinity, Na+ and Cl-dependent manner, but they differ in their tissue distribution (Borden et al., 1992; Ikegaki et al., 1994; Brecha et al., 1995) and pharmacological properties (Guastella et al., 1990; Borden et al., 1992; Brecha et al., 1992; Clark et al., 1992; Liu et al., 1993) . GABA uptake by GAT-1 is strongly inhibited by c&3-aminocyclohexane carboxylic acid (ACHC) and, to a lesser extent, by 2,4-diaminobutyric acid, but not by p-alanine (Guastella et al., 1990; Keynan et al., 1992) . These properties are often considered typical of "neuronal" transporters (Beart et al. 1972; Iversen and Kelly, 1975; Bowery et al., 1976; Larsson et al., 1983; Mabjeesh et al., 1992) . In contrast, CAT-2 and GAT-3 exhibit pharmacological properties often associated with "glial" transporters (Schon and Kelly,%l974; Iversen and Kelly, 1975; Gavrilovic et al., 1984; Kanner and Bendahan, 1990; Mabjeesh et al., 1992) , since GABA uptake by GAT-2 and GAT-3 is strongly inhibited by p-alanine, but not by ACHC (Borden et al., 1992; Clark et al., 1992; Clark and Amara, 1994) . GABA uptake by the fourth GABA transporter, BGT-1, is not inhibited by ACHC or p-alanine (Yamauchi et al., 1992; Liu et al., 1993) .
There is little information concerning the cellular expression of GATs in the cerebral cortex; GAT-1 expression is prominent, whereas GAT-3 expression is very low, and GAT-2 expression is absent (Brecha et al., 1992, 1993, and unpublished observations; Clark et al., 1992; Ikegaki et al., 1994; Kruger et al., 1994; Swan et al., 1994) . In this study, we have used ISH with GAT-I RNA probes and ICC with affinity purified GAT-1 antibodies ( Brecha et al., 1993; Johnson et al., 1995, unpublished observations) to determine the cellular distribution of GAT-1 in the cerebral cortex of adult rats.
Preliminary results have been presented in abstract form (Minelli et al., 1993) .
Materials and Methods
Tissue preparation Adult albino rats (Sprague-Dawley; Harlan, San Diego, CA), weighing 180-250 gm, were used in the present studies. Care and handling of animals were approved by the-Animal Research Committee of-the VAMC-West Los Angeles in accordance with all NIH auidelines. Rats were deeply anesthe&ed with 30% cloral hydrate and perfused transcardially with 0.01 M or 0.1 M phosphate-buffered saline (pH 7.4) followed by 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB). For electron microscopy, rats were perfused with 4% PFA plus 0.25% glutaraldehyde in PB. Brains used for ISH were stored in a solution of 20% sucrose in 4% PFA at 4°C whereas brains used for both light and electron microsconv ICC were nostfixed for l-2 hr in 4% PFA and then . . stored in 20% sucrose in PB ai 4°C. Brains were cut with a microtome or vibratome in either coronal or parasagittal plane into 20-35 or 50-100 pm thick sections, respectively. Sections were stored at 4°C in PFA until processing for ISH, and in PB for ICC.
Data and illustrations were collected from a region of the parietal cortex characterized by the presence of a conspicuous layer IV, with intermingled dysgranular regions, densely packed layers II and III, and a relatively cell-free layer Va. This area corresponds to the first somatic sensory cortex (SI; Zilles, 1985; Chapin and Lin, 1990 ).
In situ hybridization histochemistry ISH procedure. A 4.2 kb, full length rat GABA transporter cDNA clone (Guastella et al., 1990 ) was used in these experiments. Antisense and sense riboprobes were transcribed in vitro using T3 or T7 polymerase and ?S-uridine triohosohate (1.200 mCi/mmol: NEN/Du Pont. Wilmington, DL) at a-specmc activity of 3-5 X Id8 cpm/pg. Full length and partially digested RNA probes (Cox et al., 1984) were used for the ISH experiments. The ISH protocols were similar to that described in previous publications Sternini et al., 1989; Conti et al., 1994a,b) . Free floating sections were washed with glycine (0.75 mg/ml)/PBS and with 2 X SSC (0.2 M NaCl, 0.2 M NaCitrate), incubated in proteinase K (1 p,g/ml) for 30 min at 37°C followed by triethanolamine (pH 8) plus acetic anhydride for 10 min and then rinsed in 2 X SSC. Sections were orehvbridized at 37°C for 2 hr with hvbridization mixture (25 mM PIPES, pH 6.8, 0.75 M NaCl, 25 mu EDNA, 1 X Denhardt's solution (0.02% PVP 0.02% Ficoll, 0.02% BSA), 50% deionized formamide, 0.2% sodium dodecyl sulfate, 100 mu dithiothreitol, 250 pg/ml denatured salmon sperm DNA, and 250 pg/ml polyadenylic acid). Sections were then incubated in the hybridization mixture with 5% dextran sulfate and full length (or partially digested) 35S-GAT-1 Sense or antisense RNA probes (0.1 ng/pJ) overnight at 55°C. Sections were rinsed in 4 X SSC containing 5d mM B-mercaptoethanol and 10 mu NaS,O,, incubated in uancreatic RNase A (50 t&ml) for 30 min at 37°C. washed with SSC buffer at increasing stringk&y to a final wash of 0.1 X SSC at 55-65°C and then rinsed overnight in 0.1 X SSC at room temperature and mounted on slides. Sections were dehydrated through graded ethanols, air dried, and exposed to Kodak XAR x-ray film for 2-4 d. Sections were then coated with Kodak NTB-2 liquid photographic emulsion diluted 1:l with water. Autoradiograms were developed in Kodak D-19 and fixed in Kodak fixer after lo-20 d of exposure at 4°C. Finally, sections were counterstained with toluidine blue, dehydrated, cleared in xylene and coverslipped.
ISH/ICC experiments. Several series of sections were processed by ISH and by ICC with antibodies directed to glial fibrillary acidic protein (GFAP Sigma, Saint Louis, MO; Eng, 1971; Bignami and Dahli 1973) or to GAD67 (K2: Kaufman et al., 1991) . These sections were first processed for ISH as described above, and after the final wash in 0.1 X SSC they were washed in PB, incubated for 30 min in normal goat serum (NGS: 1% for GFAP and 10% for GAD67) and overnight in GFAP or GAD67 antibodies (dilution: l:lOO-200 for GFAP 1:2OiO for GAD67; in 0.1 M PB at 4°C). Sections were rinsed in PB, incubated in NGS for 15 min and then in biotinylated goat anti-mouse (for GFAP) or anti-rabbit IgG (for GAD67) at a dilution of 1:lOO for l-2 hr at room temperature. Sections were rinsed in PB, incubated in avidin-biotin peroxidase complex (ABC; Hsu et al., 1981) for l/2 hr, and rinsed in PB. Sections were then incubated in 50-75 mg/lOO ml of 3-3'-diaminobenzidine (DAB; Sigma, St. Louis, MO) and then in fresh DAB with 0.02% H,O,. Sections were then rinsed in PB, mounted on gelatincoated slides, air-dried, processed for autoradiography (as described above), and coverslipped. To determine if the two procedures interfered with each other, 10 sections of each experimental series were processed for ISH, and 10 sections (from the same animal) were processed for ICC. These sections processed by ISH/ICC, ISH, and ICC did not show any differences in the intensity and distribution of hybridization signal, or in the number of GFAP-or GAD67-uositive cells. In addition. in our experimental conditions, the morpholoiv and distribution of GFAP-or GAD67-positive cells were similar to those previously reported (Bignami and Dahl. 1973 : Ribak. 1978 : Houser et al.. 1984 : Herrera and Cuello, 1992 .
Data analysis. In our experimental conditions, autoradiograms exposed for 15 d showed the best signal/noise ratio and were therefore used for evaluating GAT-1 mRNA expression. A cell was considered "associated with grains," when silver grains were clustered over and immediately adjacent to the cell body. Sections incubated with sense RNA probes were used to evaluate and determine background levels, that were set at the mean number of silver grains/cell plus 2 SDS. Cells were considered positive when the number of silver grains they were associated with was higher than background level.
Immunocytochemistry
Antibodies. Affinity purified polyclonal antibodies (341-F and 346-J) directed to the predicted C-terminus (Guastella et al., 1990 ) of rat GAT-1 (rGAT-1 csQ .,,,) were used for these studies. Svnthetic rat GAT-1 588.599 was coupl"ed?o keyhole limpet hemocyanin (l&H) with glutaraldehyde. Rabbits were initially immunized with 100 nmol of the GAT-1 588 599 conjugated to KLH in complete Freund's adjuvant, and subsequentely immunized at 4-6 weekly intervals with 50 nmol of the GAT-1 588 599 conjugated to KLH conjugate in incomplete Freund's adjuvant. Plasma was collected after each immunization, separated and antisera were affinity purified using an Epoxy-Sepharose-GAT-1,,, 599 affinity column (Pharmica Biotech, Picataway, NJ). Purified antibodies were concentrated and stored in 0.1 M PB with 1% BSA and 0.1% NaN, at 4°C or -70°C.
GAT-1 antibodies have been characterized by immunoblocking with different predicted C-terminal peptides of cloned GABA and glycine (GLY) transporters. GAT-1 immunostaining is prevented in rat central nervous system and retina when GAT-1 antibodies were adsorbed with 10m5 M or 10m6 M rat GAT-I,,,,,,. Specific GAT-1 immunostaining is unchanged in sections incubated with GAT-1 antibodies adsorbed with 10M5M rat GAT-3,,,,,,, mouse GAT-2,,,,,,, and rat GLYT-l,,,,,, Cterminal peptides (Guastella et al., 1990 (Guastella et al., , 1992 et al., 1993) . These peptides were used because of possible cross-reactivity with rat GAT-I,,,,,,.
Polyclonal antibodies to GAD67 (K2) used in the present study have been previously characterized (Kaufman et al., 1991) .
Procedure. Coronal and parasagittal free floating sections were washed in PB, and incubated overnight in primary antiserum at a dilution of 1:500 to 1:2000 in PB containing 10% normal goat serum (NGS) and 0.5% Triton X-100 at 4°C. Sections were rinsed, incubated in biotinylated anti-rabbit IgG at a dilution of 1:lOO in PB for about l-2 hr at room temperature, rinsed in PB, and then incubated in ABC and DAB as described above. Sections were then washed in PB, mounted on subbed slides, air dried, incubated in 0.02% 0~0, for 10-20 set, washed, dehydrated, and finally coverslipped.
For electron microscopy, a mild ethanol pretreatment (lo%, 25%, 10%; 5 min each) was used before the ICC procedure. The antibody was diluted 1:700 and Triton X-100 was not used. After completion of the ICC procedure, sections were washed in PB, postfixed in 2.5% glutaraldehyde (30 min), washed in PB, and postfixed for 1 hr in 1% 0~0,. After dehydration in ethanol and infiltration in Epon-Spurr resin, sections were flat embedded between two Sigmacote (Sigma, 8Fl19)-coated coverslips. Small blocks, selected by light microscopical inspection, were cut out, glued to blank cured epoxy, and sectioned with an ultramicrotome. Thin sections were lightly stained with lead citrate or left unstained and examined in a Jeol TEM8 electron microscope.
Results
Cellular localization and laminar distribution of neurons expressing GAT-I mRNA GAT-1 mRNA was widely distributed in the central nervous system; the highest levels of hybridization signal were observed in many brainstem nuclei, including the superior and inferior colliculi, ventral tegmental area, pontine nuclei, and inferior olive, and in the cerebellum, thalamus, basal forebrain, hippocampus, olfactory bulb and neocortex (Fig. 1) . In the cerebral cortex, GAT-1 mRNA was widely and heterogeneously distributed, and there is an increased level of hybridization signal in layer IV and, to a lesser extent, in layer II.
In tissue sections incubated with sense RNA probes and exposed for 15 d, labeling was characterized by a very low density of silver grains distributed evenly in all cortical layers (Fig. 2C ). Sections incubated with the antisense probe, coated with photographic emulsion and exposed for 15 d, showed that GAT-1 mRNAs were present in all cortical layers, with layers IV and II exhibiting the highest level of hybridization signal ( Fig. 2A,B) . Positive cells were associated with a variable number of silver grains (Fig. 3) .
The large majority of negative cortical cells were small (major diameter: 4-8.3 pm; mean value: 6.1 p,m; N = 100) and they usually were darkly stained with toluidine blue (Fig. 3) , although some of these cells were associated with grains. Since the soma size, staining properties and distribution of these cells is suggestive of neuroglia, and in particular of astrocytes, we directly evaluated whether astrocytes express GAT-1 mRNA by a double labeling approach in which ISH was combined with ICC with antibodies to GFAI? The results of this series of experiments showed that most GFAP-positive cells were negative, although some express GAT-1 mRNA (Fig. 4) .
Cells whose major diameter was larger than astrocytes were considered neurons; these cells were the large majority of positive cells and were present in all layers. We evaluated next the degree of coexpression of GAT-1 mRNA and GAD67 immunoreactivity. All GAD67-positive cells were GAT-l-positive (Fig. 5) . However, not all cells expressing GAT-1 mRNA were GAD67-positive. A few neurons, including some pyramidal neurons, were GAD67-negative, but they expressed GAT-1 mRNA (Fig. 5A) . Because of the difficulty of identifying pyramidal neurons in these preparations, we evaluated these cells in layer V since they could be identified by the presence of numerous GAT-1 positive puncta covering their cell bodies. In each microscopic field centered on layer V, one or two pyramidal neurons expressed GAT-1 mRNA.
Distribution and localization of GAT-1 immunoreactivity
Specific GAT-1 immunoreactivity;(ir) was present in all cortical layers and in the underlying white matter. GAT-1 ir was associated with punctate structures, which appeared to be axon terminals, and radially oriented fibers, but not with cell bodies (Figs. 6, 8) ; GAT-l-positive fibers were also observed in the underlying white matter and were particularly numerous in the corpus callosum. Specific immunostaining was not observed in control sections incubated with GAT-1 antibodies adsorbed with rat GAT-l,,,.,,, (Fig. 7C) . No changes in immunostaining patterns were seen in sections incubated in GAT-1 antibodies that were adsorbed with GAT-3 or GLYT-1 C-terminal peptides (Fig.  7A,B) .
The same pattern of GAT-l-positive puncta was observed in all sections from several animals. Furthermore, comparable im- Figure 5 . Simultaneous visualization of GAD67-ir and GAT-1 mRNA in rat cerebral cortex shows that all GAD67-positive cells express GAT-1 mRNA, but that not all GAT-1 mRNA expressing cells contain GAD67-ir (arrows). Of these, some are pyramidal neurons, as revealed by the dense clustering of GAD67-positive axon terminals on their somata and proximal dendrites (A). In A, asterisk indicates a pyramidal neuron not expressing GAT-1 mRNA. Exposure time: 15 d. A, Layer V, B and C, II. Scale bars: 20 Frn. munostaining patterns were also observed in all cortical areas. The following description of the immunostaining pattern is from SI cortex.
GAT-l-positive puncta were relatively sparse in layer I, although the most superficial portion of this layer contained numerous puncta and horizontally or obliquely oriented fibers (Figs. 6A, 8C,D) . Layers II-III (especially the lower portion of the latter) contained numerous immunoreactive puncta and fibers (Fig. 6) . Layer IV showed the highest level of intensely stained and densely packed puncta (Fig. 6) . Overall, infragranular layers exhibited a much lower intensity of staining than layer IV or supragranular layers (Fig. 6 ). However, a band of increased intensity of staining was over the lower portion of layer V (layer Vb; Fig. 6A ). Numerous immunoreactive fibers, usually running obliquely or radially and showing irregularly spaced varicose swellings, were observed in infragranular layers, particularly in layer VI (Fig. 8D) .
GAT-l-positive puncta were observed throughout the neuropil and they appeared to have a preferential relationship to the soma and proximal dendrites of cortical neurons (Figs. 6, 8A,B) . Puncta were so numerous around some neuronal perikarya that they appeared to form continuous sheets (Fig. 8A,B) . In layers II-III and V-VI, numerous GAT-l-positive puncta were observed around the somata and the proximal portions of the apical dendrites of pyramidal cells (Fig.. 8A,B) , although GAT-l-positive puncta were also observed in close apposition with distal dendrites (Fig. 8) . In the majority of the cases, the distribution of the GAT-l-positive puncta distinctly outlined unlabeled pyramidal cells. GAT-l-positive puncta were, however, also noted around cells that did not have the appearance of pyramidal cells (Fig. 8) . In layer IV, GAT-l-positive puncta formed clear outlines of numerous round, small-sized and densely packed cells, which are likely to be nonpyramidal neurons.
The distribution of GAT-1 and GAD67 ir were directly compared in adjacent sections. The distribution of GAD67 ir in SI of a non-colchicine-treated adult rat (Fig. 6C ) is in agreement with previous descriptions (Houser et al., 1984; Esclapez et al,, 1994) . The patterns of distribution of GAD67-and GAT-l-pos- itive puncta are remarkably similar, with the exception that CAT-1 ir is more evident than GAD67 ir in layers II-III. Furthermore, there is a similar relationship between GAD67-and GAT-1 -positive puncta with neuronal perikarya and proximal dendrites ( Fig. 8A,B; see Ribak, 1978, and Houser et al., 1984) . The ultrastructural pattern of ,labeling for GAT-1 was similar in all layers of the cortex. Immunostaining, in the form of electron dense reaction product, was mostly found in axonal and glial profiles, whereas somata and dendrites were unlabeled (Fig.  9) . Axonal labeling was present in the axoplasm of thinly myelinated axons (Fig. 9A) and in numerous presynaptic axon terminals (Fig. 9%D) . Labeled terminals were heterogeneous in size and shape, but all formed symmetrical synaptic contacts (Fig. 9B-D) . The profiles postsynaptic to the immunopositive terminals were unlabeled cell bodies (Fig. 9B) or dendrites of all sizes (Fig. 9C,D) . Adjacent terminals with asymmetric synaptic specialization were always unlabeled (Fig. 9B-D) . Reaction product was also found in distal astrocytic processes (Fig.  9&G) , identified by the tortuous plasma membrane that interleaves among unlabeled axonal and dendritic profiles (Fig. 9&F) or by their perivascular position (Fig. 9G) . Astrocytic cell bodies, oligodendrocytes and microglial cells were unlabeled. Occasionally, weak immunolabeling (not illustrated) was observed in the cytoplasm of cell bodies characterized by nuclear infoldings and along the membranes of their organelles, particularly Golgi cisterns. Analysis of sections reacted with the GAT-1 antibody preadsorbed with 10e5 M rat GAT-3607.627 showed that the pattern of ir was identical to that observed in sections processed with the GAT-1 antibody. Discussion GAT-1 is prominently expressed in the neocortex of adult rats, and it is localized to both neurons and astrocytic processes. The majority of neurons expressing GAT-1 mRNA contain GAD67 immunoreactivity and are the source of GAT-1 immunoreactive axon terminals forming symmetric synapses. However, a few pyramidal cells also express GAT-1 mRNA. These results indicate that the magnitude of the cortical GABA uptake system is more extensive than previously believed and suggest that the GAT-1 uptake system may have important regulatory roles which would influence cortical information processing.
CAT-1 expression in cortical astrocytes Numerous astrocytic processes are GAT-1 positive, whereas other glial cells in the cortex or in the underlying white matter are not labeled with antibodies to GAT-1. The possibility that the GAT-1 antibodies might have cross-reacted with GAT-3, which is expressed by astrocytes in culture (Borden et al., 1994b) and by Muller cells (Johnson et al., 1995, unpublished observations) can be excluded, since preadsorbing GAT-1 antibodies with GAT%o,-m did not abolish astrocytic immunoreactivity. However, we can not rule out the possibility that GAT-1 antibodies may have cross-reacted with other unidentified membrane proteins. The immunocytochemical observations are, however, supported by GFAP/GAT-1 mRNA double labeling experiments, which showed that some GFAP-positive cells express GAT-1 mRNA.
GAT-1 expression in glial cells has also been reported in retinal Muller cells (Brecha and Weigmann, 1994; Johnson et al., 1995, unpublished observations) , in hippocampal astrocytic processes (Ribak and Brecha, 1994; C. E Ribak, W. Tong, and N. C. Brecha, unpublished observations) , and in the electromotor nucleus of Torpedo (Swanson et al., 1994) . Together, these observations show that GAT-1 is expressed by neurons and astrocytes, in contrast to previous suggestions that neurons and astrocytes express different GABA transporters (Iversen and Kelly, 1975; Mabjeesh et al., 1992) . The present observations also extend earlier studies that indicated that "neuronal" and "glial" GABA transporters are not always separable on the basis of pharmacological criteria (Cummins et al., 1982; Levi et al., 1983; Reynolds and Herschowitz, 1986) . Interestingly, Clark et al. (1992) showed that mRNAs encoding for GAT-3, a presumed "glial" GABA transporter, are expressed also in brainstem neurons.
CAT-1 expression in cortical neurons and axon terminals Overall, the distribution pattern bf neurons expressing GAT-1 is reminiscent of that of GAD-or GABA-immunoreactive neurons, although the number cells expressing GAT-1 mRNA appears higher than that of GAD-or GABA-positive neurons. Doublelabeling experiments in which GAD67 ICC has been combined with GAT-1 ISH showed that (1) all GAD67-positive cells contained GAT-1 mRNA, and (2) some GAD67 negative cells, belonging to both the nonpyramidal and the pyramidal classes of cortical neurons, are associated with an above-background number of silver grains. Since we used the polyclonal antiserum K2 (Kaufman et al., 1991) that recognizes primarily GAD67, it is possible that some GAT-1 positive/GAD67 negative neurons contain GAD65 or that GABA synthesis is mediated by other 7742 Minelli et al. l GAT-1 in the Cerebral Cortex Figure 8 . GAT-1 immunoreactivity within punctate structures that represent probable axon terminals (A and B) and in some fibers (C and D).
The cell bodies and primary dendrites of both pyramidal (asterisk) and nonpyramidal (arrowhead) cells are outlined by stained axon terminals. Scale bars: A, 15 p.m; B, 10 pm; C and D, 20 p,m. enzymes (Erdo, 1985) . Whereas this explanation may account for the labeling of nonpyramidal GAT-1 positive/GAD67 negative neurons, it does not account for GAT-1 mRNA containing pyramidal cells, in which GABAergic markers have never been reported. The observation that some pyramidal neurons express GAT-1 mRNA, therefore, shows that at least some nonGABAergic neurons do indeed express GAT-I, a finding that implies the existence of a postsynaptic GABA transporter. The functional significance of this observation remains to be established for these cells; for instance, the presence of GAT-1 on the dendrites and soma of these cell bodies would be functionally important, since GABA exerts most of its action at these sites on pyramidal neurons (DeFelipe and Farinas, 1992) . The present finding that some neurons express transporters for neurotransmitters different from those released by their axon terminals is in line with the results of a recent ICC study, which showed that one of the recently cloned glutamate transporters, EAACl (Kanai et al., 1994) , is not confined to glutamatergic neurons, but is also present in nonglutamatergic neurons, such as Purkinje cells (Rothstein et al., 1994) .
The morphology, laminar distribution and synaptic relationships of GAT-1 positive axon terminals is similar to that reported for GAD-and GABA-positive axon terminals (Ribak, 1978; Houser et al., 1984) . GAT-1 positive puncta were not quantified, but they seem to be more numerous than GAD67-positive puncta. This difference may be due to the fact that GAT-1 is a more robust marker of GABAergic axon terminals than GAD67, or may simply reflect the higher number of GAT-l-positive neurons than that of GAD67-positive neurons.
The large majority of axon terminals forming symmetric synapses on pyramidal and nonpyramidal neocortical neurons arise from several types of nonpyramidal cells, including smooth and sparsely spinous neurons with local plexus axons, and basket, chandelier, and double-bouquet cells (Peters, 1987) , which have been shown to be GABAergic (Somogyi and Martin, 1985; Hendry and Carder, 1992; Jones, 1993, for reviews; and Kisvarday et al., 1990 , for data on human cerebral cortex). In addition, axon terminals from basal forebrain GABAergic neurons form symmetric synapses in the neocortex (Freund and Meskenaite, 1992) . These observations provide further support to the suggestion that a large proportion of neurons and axon terminals expressing GAT-1 mRNA corresponds to GABAergic neurons and synapses.
All pyramidal neuron axon terminals form synapses of the asymmetric type (Winfield et al., 1981; McGuire et al., 1984) ; since a few of these cells contain GAT-1 mRNA, some asymmetric synapses may also contain GAT-1. However, GAT-1 immunoreactivity was not detected in axon terminals forming asymmetric synapses. This may be due to the presence of GAT-1 levels below the threshold for immunocytochemical detection or may reflect the paucity of such terminals.
GAT-l-mediated GABA uptake system in the cerebral cortex: correlation with GAD-containing system and functional implications The major conclusion that emerges from the present study is that in the cerebral cortex the GABA uptake system mediated by GAT-1 is strongly expressed and that it is more extensive than the GABA synthetizing system. This conclusion raises two issues bearing on the proposed cell specificity of neurotransmitter transporters and on the function(s) of GABA and GABA transporters in the cerebral cortex.
First, early studies on the localization of neurotransmitter transporters emphasized the coincidence between their distribution and that of synthetizing enzymes or other markers for the same transmitters, and led therefore to the notion of cell specificity of neurotransmitter transporters (Uhl, 1992 ). The present evidence shows that the distribution of one such transporter, GAT-1, is indeed largely coincident with that of other GABAergic markers, but at the same time argues against a dogmatic view of cell specificity or limits it to other neurotransmitter transporter systems (Uhl, 1992) , since we have shown that GAT-1, a "neuronal" transporter, is localized to both neurons and glia, and that neurons expressing GAT-1 are heterogeneous in terms of morphology, transmitter phenotype, and function (see also Bonanno and Raiteri, 1992; Kimelberg, 1992) .
Second, the present evidence that most GAT-1 is expressed in axon terminals forming symmetric synapses is in agreement with the classical notion that the main function of GABA transporters, like other neurotransmitter transporters, is to reaccumulate released transmitters into presynaptic terminals and vesicles, thus aiding at terminating the overall process of synaptic transmission and contributing to transmitter recycling into synaptic vesicles. This localization is also consistent with the possible Ca2+-independent, nonvesicular, release of GABA during synaptic activity or depolarization (Attwel et al., 1993) . In addition, the localization of GAT-1 to axon terminals and astrocytic processes fits with several physiological studies that suggest that GABA uptake regulates GABA action at its receptors, and that GABA acts in a "paracrine" manner on presynaptic G-protein-coupled GABA, receptors located on excitatory axon terminals (Dingledine and Korn, 1985; Thompson and Gahwiler, 1992; Isaacson et al., 1993) . Interestingly, the GABA uptake inhibitors tiagabine and SKF-89976A, which are specific for GAT-1 (Borden et al., 1994b) , selectively enhances the presynaptic action of GABA on presumed GABA, receptors on excitatory nerve terminals (Thompson and Gahwiler, 1992; Isaacson et al., 1993) . Since a few pyramidal neurons express GAT-1 mRNA, it is possible that GAT-1 is on axon terminals that release glutamate or another excitatory amino acid (Conti et al., 1987 (Conti et al., , 1989 DeFelipe et al., 1988; Dori et al., 1989) .
